All things being relative, 2013 was a pretty good year for M&A in pharma. There were 169 deals valued at $76 billion last year, according to the information ninjas who dice the numbers at EvaluatePharma. That was a 15% jump in the number of deals and a 33% increase in the dollars spent compared to 2012. Analysts had expected as much from 2013, however, because 2012 was the low point for M&A in many years.Read more: Pharma's top 10 M&A deals of 2013 - FiercePharma http://www.fiercepharma.com/special-reports/top-10-ma-deals-2013#ixzz2zDDickJ7
Subscribe at FiercePharma
No comments:
Post a Comment